Bo Chen

机构：Shenzhen Metro (China), Xi'an Medical University, Chongqing Medical University · ORCID：0000-0003-4346-0755

发表论文 49 篇 · 总被引 3162 次 · h-index 20

代表论文

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial (2020 · medRxiv · 被引 795)
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine (2022 · Nature · 被引 218)
Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis (2021 · Journal of Clinical Investigation · 被引 130)
Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance (2021 · Cell Reports · 被引 68)
Exploration and breakthrough in the mode of chondrocyte death - A potential new mechanism for osteoarthritis (2023 · Biomedicine & Pharmacotherapy · 被引 37)
Membrane vesicles from Lactobacillus johnsonii delay osteoarthritis progression via modulating macrophage glutamine synthetase/mTORC1 axis (2023 · Biomedicine & Pharmacotherapy · 被引 37)